In recent months, Lam Research has reported strong fiscal Q2 2026 results, expanded collaborations with IBM and CEA-Leti, and continued to benefit from elevated AI-driven demand for its etch and deposition tools across DRAM, HBM, and advanced logic production.

A particularly interesting development is billionaire investor Ray Dalio’s Bridgewater Associates more than doubling its Lam Research stake in 2025, underscoring growing institutional attention to the company’s role in AI-centric semiconductor manufacturing.

We’ll now examine how Lam’s AI-related demand strength and new IBM collaboration may reshape its existing investment narrative and risk profile.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 21 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

To own Lam Research, you need to believe AI-led demand for DRAM, HBM and advanced logic will keep pulling through more etch and deposition tools, while Lam maintains its process leadership. The key near term catalyst remains AI infrastructure capex translating into sustained orders and high utilization of Lam’s installed base; the biggest current risk is a reversal in memory and foundry spending or tighter export rules. The latest news, including Dalio’s position increase, does not materially change those drivers.

The new IBM collaboration around sub 1 nm logic scaling is the announcement that most directly reinforces Lam’s AI narrative. It ties the company’s core strengths in etch, deposition and High NA EUV integration to future nodes that underpin data center, HBM and advanced packaging demand. If those IBM enabled process flows gain traction at leading foundries, they could support Lam’s order visibility around its most important AI related catalyst.

Yet investors should also keep a close eye on how export controls and customer concentration could affect Lam’s China exposure and long term margin profile…

Read the full narrative on Lam Research (it’s free!)

Lam Research’s narrative projects $23.6 billion revenue and $6.7 billion earnings by 2028.

Uncover how Lam Research’s forecasts yield a $274.90 fair value, a 26% upside to its current price.

LRCX 1-Year Stock Price Chart

LRCX 1-Year Stock Price Chart

Some analysts were already far more optimistic, assuming Lam could reach about US$41.6 billion in revenue and US$15.4 billion in earnings, but the latest AI and collaboration news might either support that bullish view or force a rethink, so it is worth comparing how differently you and those analysts weigh that upside against the risk of tighter export rules.

Explore 10 other fair value estimates on Lam Research – why the stock might be worth 48% less than the current price!

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

Every day counts. These free picks are already gaining attention. See them before the crowd does:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include LRCX.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com